z-logo
open-access-imgOpen Access
Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa
Author(s) -
Jonathan D Cogen,
Frankline Onchiri,
Nicole Hamblett,
Ronald L. Gibson,
Wayne J. Morgan,
Margaret Rosenfeld
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab208
Subject(s) - achromobacter xylosoxidans , medicine , antibiotics , pseudomonas aeruginosa , cystic fibrosis , hazard ratio , pseudomonas infection , proportional hazards model , microbiology and biotechnology , confidence interval , bacteria , biology , genetics
While Pseudomonas aeruginosa (Pa) eradication regimens have contributed to a decline in Pa prevalence in people with cystic fibrosis (CF), this antibiotic exposure might increase the risk of acquisition of drug-resistant organisms. This study evaluated the association between antipseudomonal antibiotic exposure intensity and acquisition risk of drug-resistant organisms among children with CF and new Pa infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here